Part 1 of 7: INTRO / OVERVIEW- narrator (Olivia) 1:34
Program presents background on the NON-INVASIVE ENERGY treatments throughout history and how the wellness community has continued supporting this paradigm through the expansion of ELECTROMAGNETIC stimulation and the advancements of ULTRASOUND for diagnostic care. Introduction of Dr. Robert Bard,. lead presenter of imaging validation of non-invasive electronic therapies.
Part 2 of 7: Dr. Bard: 4:04
Dr. Bard introduces advantages of ultrasound for scanning the results of "invisible therapeutics". He presents historical landmarks of PEMF with the FDA, then expands the many models of ultrasound available in the market.
Part 3 of 7: ABOUT BLOOD FLOW- narrator (Olivia) 0:45
Ultrasonic pulse-echo systems can provide range-finding, time-position and real-time two-dimensional images of soft-tissue structures within the body. The Doppler effect can be used to study motion and blood flow. Continuous wave Doppler instruments provide information about velocity and direction of flow; depth discrimination can be obtained by pulsing the ultrasound.
Advanced Digital Imaging technologies provide accurate use of sound waves to produce real-time images of the inside of the body.
Part 4 of 7: Dr. Bard
Dr. Bard continues his review of the use of ultrasound as a 'tool of choice" for validating non-invasive electronic therapies. He goes deeper in the more common MSK injuries through scanning while identifying these disorders visually through quantitative scanning analyses of the various ultrasound features.
Part 6 of 7: (EXTRA) Dr. Jerry Dreessen presents his expertise on how PEMF works with his patient care. Discusses his approach on how to get the most out of the application design of ElectroMagnetic Stimulation. see LINK
Part 7 of 7: EPILOGUE/ The Non-Invasive Movement (Olivia) 0:40
The modern NON-INVASIVE diagnostic movement is comprised of our many existing discoveries including near-infrared and cold laser, sound waves, pulsed electromagnetic fields and other electronic emissions to collect vital information on a patient's state of health.
Today, the medical community continues to advance our ultrasound imaging capabilities to include quantitative features in high-powered Sonograms, sonfluoroscopy and 3D/4D Doppler Imaging.
SCANNING PHYSIOLOGICAL RESPONSE Dr. Robert L. Bard publishes a non-commercial review of select non-invasive diagnostic and treatment technologies for his program "Bard Tech Reviews" to be found in the newsletter, JOURNAL FOR MODERN HEALING. This is a public blog-style site where he promotes the use of medical imaging technologies and his clinical expertise in diagnostic interpretation / analyses of all scanned readings. He provides this review to the open public as part of an educational initiative to support beta testing, strategic efficacy research protocols and the value of analytical confirmation, second opinions and use of non-invasive imaging.
THERAPEUTIC DEVICE EFFICIACY STUDY
Dr. Bard's reporting is by no means directed to support the marketing of any brand, company or developer. Mention of any brand (if at all) are only to credit those used in the tech review as "source". His objectives in Tech Reviews is to report on the immediate physiological effects of any medical device under review using ultrasound and other non-invasive scanning methods. All results are based on a BEFORE-AND-AFTER visual comparison and a clinical interpretive description of the imaging graphic - thus aiming to show the body's potential reaction to that device (if any) by virtue of an after-treatment applied scan.
Dr. Bard's scan studies are not designed to support any device's claims to conclude the efficacy of the treatment as a cure in any way, and all tests performed and scanned are presented only as ANECDOTAL findings. By this, unless the test has been IRB instituted (where he is clinically allowed to work on other consenting patients), Dr. Bard's tech review of therapeutic devices are to be applied ONLY on his own person, where his scans and reports are limited to his personal evaluation of observed potential findings.
TYPES OF APPLICATIONS 1) "USE AS INSTRUCTED": All devices under FDA approval (via 510K) are presented publicly to perform a specific function under an exact application. Dr. Bard's beta testing and scanning review provides a visual review of the device's effects on the body as labeled.
2) "OFF-LABEL USE": Certain devices are accepted in MedTech Reviews under the sole discretion of Dr. R. Bard for exploratory research if the concept of the technology protocol (not necessarily the specific model in hand) may show published potential response to manage or address other disorders that have not yet earned FDA clearance or approval. Exploratory reviewing is completely academic in its nature, seeking to duplicate these experimental uncleared applications for any evidence of the pre-published statements in the name of science.
Fall 2021 Review: Non-Invasive Therapeutics
WEARABLE MSK NEUROSTIM THERAPY TECHNOLOGY: In 2015, Dr. Oz aired a program about an "invisible treatment" for chronic pain designed to "change the practice of medicine"- casting a wave of commercial attention to the patient community desperate for pain relief- and hope for the reversal of pain-related ailments. Pulsed Elecromagnetic Field Thereapy or PEMF is the induction of electromagnetic fields to promote the synthesis of cellular, muscular and skeletal matrix.
Electromagnetic fields (EMFs) provide a non-invasive, safe, and easy method to treat and rehabilitate a growing list of health issues. The therapeutic theory behind this innovation is designed to affect the body at the extracellular level- imposing the ability to transduce or separate mechanical charge to electrical energy. This has been reported to affect the alignment and physical properties of tissues & cell nutrition toward the healing process.[2] Electromagnetic fields (EMFs) and magnetic therapy presents a major increase in research attention in the past decade for its ability to directly treat the site of injury (See complete report)
PEMF STUDY EXTRA: Osteoarthritis in the Hand: Observed Response In a observational review from an unrelated patient study, a 70+ year old female expressed increasing difficulty in daily hand functions like sewing, folding clothes and dish washing. X-ray was done by a hand surgeon which showed arthritis of the first metacarpophalangeal joint. The bones were too close reducing range of motion in the thumb because the cartilage separating the bone was degenerated completely, validating the diagnosis of arthritis in the hand. The surgeon concluded Osteoarthritis and this symptom is stated to be the most common finding in hand arthritis.. (See complete report)
The Modern Age of Non-Invasive Mental Health Innovations: TRANSCRANIAL MAGNETIC STIMULATION (TMS): In the continued expansion of the medical society to “go non-invasive” (or non-surgical) and the trending reassessment of interventional medications, the mental health community has acquired major tools in its toolbox to support clinical diagnostic and treatment efforts. In 2008, the FDA approved the first TMS Depression Device for Depression Treatment [1]. In 2018, the FDA approved the marketing of Repeated Transcranial Magnetic Stimulation (rTMS) as adjunct therapy for of obsessive compulsive disorder (OCD).
Current reports have presented an est. 30% of depression cases have a resistance to antidepressant drugs, where Transcranial Magnetic Stimulation (TMS) and the application of Transcranially applied non-invasive neuro-magnetic intervention has shown positive results in combination with antidepressants in patients with treatment-resistant depression[ 4]. (See complete report)
MedTech* Pain Therapeutic Device
WEARABLE MSK NEUROSTIM THERAPY TECHNOLOGY: The American pain relief treatment industry is expansive and a vastly lucrative market. It appeals greatly to the population that is drawn to the 'promise' of restoring quality of life and physical performance through the reduction/elimination of stress and discomfort. The varying range of pain treatment strategies on the market lends itself to a seemingly endless array of options for products, technologies, drugs and point of care therapies. MedTech Reviews takes on the commitment to challenge the efficacy of a selected brand based on their claims of pain therapy from their wearable therapeutic innovations. For this product review, our efficacy testers and claim challengers brought us AXIOBIONICS. In this unique observational report, Dr. Bard performs as both the actual patient (for his various physiological injuries and chronic pains) + the investigative imaging specialist, providing a complete assessment of the therapeutic process + extensive regular scanning of the musculoskeletal effects of the devices in question. (See complete report)
FLUORESCENCE IMAGING FOR INFLAMMATION & INFECTION
From a 2019 study (by Raizman et al) about use of this technology (MolecuLight i:X) with debridement, scans of 22 wounds were conducted under standard and violet light in patients after debridement. Scans, performed non-invasively at the point-of-care, demonstrated remaining bacteria/biofilm signal in 100% of wounds after sharp debridement, triggering additional removal of tissue. Fluorescence imaging is proven to have a four‐millimeter depth of diagnostic accuracy in the tongue or mucous membranes‐ similar to the cervix or the vagina or the intestine lining... and reports on its use in skin wounds and wound infection. However, it's use in skin diseases has not been fully explored. .(Article review)
TRANSCRANIAL DOPPLER (TCD) IMAGING - Article
Since the advent of ultrasound scanning in the 1950's, the global movement to develop and expand its diagnostic features continue in its appeal with the medical community today. Hemodynamics is defined as the study of blood flow in relation to the status of the circulatory system and homeostatic mechanisms of autoregulation. Through the monitoring of blood flow, diagnostic analysis can provide many answers to the health and physiological status of the target area scanned as well as cell-level metabolism, the regulation of the pH, osmotic pressure and temperature of the whole body, and the protection from microbial and mechanical harm.. .(Article review)
SAMPLE REVIEW: NON-INVASIVE MOVEMENT IN CANCER IMAGING (Video - 3min)
Featuring global advancements in Elastography, digital Pet/CT scans, MRI and the Doppler Ultrasound scanning - all supporting quantifiable readings that successfully reduce/prevent unnecessary biopsies and false positives. The movement to Integrate current cancer scanning modalities paves the way for a faster, and a more accurate way of tracking cancer aggression, allowing for the adjustment of therapies
as needed in a timely manner. (Versions: ENGLISH | ITALIAN | DUTCH/beta- in development)
SAMPLE REVIEW: THE PORTABLE ULTRASOUND - Pilot Video | Article
To stay current with today's medical needs, the PORTABLE HAND-HELD ULTRASOUND DEVICE - aka the "modern stethoscope" joined the market. Powered by calibrated sound frequencies, this non-invasive scanning solution safely diagnoses the physiological condition of most vital organs and tumors in real time. The pocket-sized smart-phone integrated advancement clearly competes in resolution and performance with the over-sized hospital counterparts at a fraction of the cost! . (see Video) (Article review)
SURGICAL EVOLUTION IN BREAST CANCER LOCALIZATION: WIRE-FREE RADAR IMPLANTS -
Wire-free Radar Localization is a pre-surgical procedure developed to locate and mark the exact breast abnormality through the use of a small, 12×1.6 mm implanted radar reflector device, roughly the size of a grain of rice. This micro-electronic implant communicates with the scanning handpiece, allowing the surgeon to identify the exact tissue (and how much of it) to extract during a lumpectomy. Surgical experts and diagnostic analysts present first-hand benefits and technical perspectives behind radar localization and the SCOUT® technology and the procedural advantages provided by the wire-free upgrade... (See feature article)
SEMINAR: IMAGING FOR PANCREATIC CANCER MONITORING (Video - 6min)
Explore the current technologies used in real-time tracking of Pancreatic Cancer. In patients with a family history of genetic cancers or who are otherwise at a high risk of pancreatic tumors, having the latest innovations and resources for identifying and tracking these tumors makes all the difference in every part of the treatment process. Since we're trying to avoid radiation and biopsies at any time, we use ultrasound screening as the first line scan to image the pancreas. (see Video)
INTUITIVE TECH RESEARCH & REVIEWS - By: Dr. Robert L. Bard
Since the start of my career in the USAF medical corps, I have always held the most profound respect for NON-INVASIVE MEDICAL TECHNOLOGIES. I have witnessed the growth and expansion of safer and faster alternatives like the expanded uses and features of the ULTRASOUND, whereby in mere seconds, you can scan a patient's condition and & map out an entire treatment program from a "simple" pass of a transducer (probe). The movement of NO CUTTING and NO INJECTING means a completely visionary and streamlined upgrade to the entire patient care protocol.
BETA TESTING: MY COMMITMENT TO THE NEXT GENERATION - More than a "Tech Critic", my 35+ years in the clinical trade was the best position to give me complete access to all the latest technologies (globally), and be a TEST DRIVER of some of the most brilliant discoveries and innovations before they hit the open market. I conduct real-world applications of prototypes and even stretch its engineering limits (also known as 'battle testing') which leads to my publishing a comprehensive report support for the medical and patient communities. I take the responsibility of challenging developers' claims or validate their efficacy. I find great value in this information for use in my own practice as well as sharing this with all my colleagues across the globe. In the end, I only hope to contribute my findings to the ever-growing technology trends and advancements for patient care.
MedTech* Real-Time Remote Test Drive
PATIENT REMOTE HOME SCREENING: COVID PATIENT
April 2020- Patient 1 was quarantined due to a covid-positive test reading. MedTech Reviews producers & certified medical advisors led by Dr. Robert Bard assembled this prototoype home-based self screening & remote monitoring plan- using the Terason 3200T. For 7 days, a Terason technical representative partnered with our radiology team to conduct the daily monitoring in real-time both through video conferencing & scan/file sharing from various geographic locations. Complete tracking reports, imaging logs and video interviews with the patient during the self-screening process made for a successful example of remote patient diagnostic access & group collaboration using WIFI technology & advanced digital communication. (See complete review)
MedTech* News Reports
As a cancer imaging specialist, I have the highest regard for all my colleagues who offer some of the most remarkable advancements in medical care. Major installations like the CyberKnife System, Proton Therapy, Robotic surgical technologies and the latest in AI-Powered MRI systems are just some of the breakthroughs shaping the battle against cancer and other disorders. I report on their many life-saving advantages and support the great science that goes into their development.
Originally Published in: The Journal of Modern Healing
CANCER TREATMENT TECH REVIEW: ADVANCEMENTS IN PROTON THERAPY:The concept of the pencil beam scanning or IMPT (intensity-modulated proton therapy) has grown widely accepted as the ‘new future’ in radiation therapy. This dose is deposited within a controlled range of depth, affecting specific coordinates in the body so most of the dose is delivered to the actual tumor and little or no radiation is delivered to tissues beyond the tumor. This system is globally recognized to treat brain tumors, prostate, breast, liver, lung, head and neck, and other cancers. (SEE ARTICLE LINK)
From PREVENTION101 THE PULSE OXIMETER is an electronic device that clips onto a patient’s finger to measure heart rate and oxygen saturation in his or her red blood cells—the device is useful in assessing patients with lung disease. Almost a year into the pandemic, we have seen waves of empty shelves of specific items due to panic shopping or the recent burst of proactive health trends. This reflects a significant part of "the Covid Culture"- comprising the demand for personal safety measures (beyond the holy trinity of masking, distancing and hand hygiene). (SEE ARTICLE LINK)
From NYCRA NEWS ROBOTIC MASTECTOMY and the DA VINCI SURGICAL SYSTEM Since the first recorded successful surgical procedure in 1985 launched the trend of robotic assisted surgeries have widely expanded in growth and demand - supporting the complexities of Heart, Thoracic, Gastrointestinal, Gynecological, Spine, This review explores the latest work of Dr. Stephen Chagares, the first American surgeon to conduct the robotic mastectomy and his innovation of choice. (SEE ARTICLE LINK)
From NYCRA NEWS CYBERKNIFE TECHNOLOGY (part 1):Since the advent of radiation therapy (and the invention of the x-ray) over a century ago, the noninvasive treatment approach of radiotherapy continues to be recognized as one of the most forward-thinking technologies in the pursuit of targeting cancer tumors. The CyberKnife® Robotic RadioSurgery System represents the latest performance innovation in this modality for treating benign and malignant tumors as well as other chronic disorders. (SEE ARTICLE LINK)
From Modern Diagnostic Science (8/2019)- by Dr. Manu Jain / MSKCC REFLECTANCE CONFOCAL MICROSCOPY (RCM) gives dermatologists a major upgrade (over age-old microscopy) in their ability to assess pathologic and physiologic conditions of the skin with a higher level of clinical accuracy, greatly supporting the reduction of calls for biopsies of benign lesions. This system gathers epidermal and superficial dermal information through the use of LIGHT and laser. It penetrates the skin to reach an estimated 200 microns in depth –often useful in dermatology to diagnose skin cancers like melanoma, basal cell carcinoma and squamous cell carcinoma. (SEE ARTICLE LINK)
From NYCRA NEWS TOURING ACURAY: CYBERKNIFE® DEVELOPMENTToday's engineering and medical technology (from the late 1980s) show significant evidence of ethical standards and major consideration for patient response. Ethics in treatment engineering covers all angles considered about the innovation including: the way it is built, the materials applied, the engagement of the operator and the aftermath of the patient.. “Historically, radiation CAUSED cancer, but that's because you didn't have precision then....So the more precise you can be, the better - and we (Accuray) pride ourselves on exquisite and unparalleled precision,” says Ms. Fleurent.(SEE ARTICLE LINK)
Disclaimer: All content in the MedTech Reviews* and MedTech News* section are assembled excerpts of actual articles written, co-written or produced by Dr. Robert Bard and are published in the various media publications as stated. Each article in the form of medical technology feature reviews or educational reportsare samples of Dr. Bard's body of work. The manufacturers / developers, medical centers, corporate entities or practitioners mentioned in these reviews are NOT presented on this page or the MedTech program for any commercial purposes nor have any direct business ties to the Angiofoundation or the producers/publishers in any way.
Media
Dr. Bard is highly involved with public education both in the private and public circuits. These are just a few recent samples of his "social media shorts". For all his other media coverage including news features, please visit his media section by clicking THIS LINK.
